Representing community pharmacy, working in collaboration with others, to improve the quality of health and well-being of the people in our counties. At present we represent 117 community pharmacies across Herefordshire and Worcestershire.
Pharmacy owners can now watch a recording of CPE's online workshop on completing the 2026 Data Security and Protection Toolkit ahead of the 30th June submission deadline.
CPE will be holding a series of regional roadshow events across the country in 2026. The West-Midlands event is on 30th June.
Enter the best awards ceremony for independent community pharmacy and shout about your achievements! The deadline for entries is 22nd July.
We would like to remind all community pharmacies about the appropriate practice of patient nominations. Please remember that Electronic Prescription Service (EPS) nominations must be…
Please find attached details of pharmaceutical provision across Herefordshire and Worcestershire for the May 2026 Bank Holidays: Early May Bank Holiday Monday 4th May 2026…
We are pleased to announce the launch of the Community Pharmacy Technician Apprenticeship Programme (CPTAP) 2026. This programme supports Pre-registration Trainee Pharmacy Technicians (PTPTs) to…
We have a new patient-facing website for Community Pharmacy Herefordshire and Worcestershire. The Herefordshire and Worcestershire Pharmacy website serves as an online hub connecting residents…
Please find below information regarding your Bank Holiday opening intentions for August 31st 2026. Bank Holiday Opening Intentions Pursuant to paragraph 35(3)(b) of Schedule 4…
The Community Pharmacy Patient Safety Group (CPPSG) has released two resources aimed at supporting community pharmacy teams with Opioid Treatment Programmes: “Focus on Methadone”, video…
Community Pharmacy England’s annual regional roadshow series returns in less than a month, kicking off with events in Yorkshire & the North East in the…
MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) Drug alert number: EL(26)A/23 Date issued: 11 May 2026 Milpharm Limited has…
NHS IT teams want to learn how community pharmacy owners and decision makers decide which services IT system to use or move towards when system…
The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise…
Eligible pharmacists in the East and North Midlands have been invited to express interest in joining Community Pharmacy England’s Committee. Expressions of Interest are now…